This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
HAMSTER anti Mouse CD3:Biotin
catalog :
MCA2690B
quantity :
0.1 mg
price :
273 USD
clonality :
monoclonal
host :
hamsters
conjugate :
biotin
clone name :
145-2C11
reactivity :
mouse
application :
flow cytometry
product information
EntityType :
Monoclonal Antibody
EntityCategory :
Antibodies
ProductCode :
MCA2690B
Description :
HAMSTER ANTI MOUSE CD3:Biotin
Specificity :
CD3
TargetSpecies :
Mouse
Host :
Hamster
Format :
Biotin
Conjugate/Tag :
Biotin
Isotypes :
IgG
Applications :
F
ApplicationTypes :
Flow Cytometry
Clone :
145-2C11
Quantity :
0.1 mg
QuantityValue :
0.1
QuantityType :
mg
GOAccessions :
GO:0001772, GO:0002669, GO:0016021, GO:0004888, GO:0008624, GO:0009897, GO:0032729, GO:0032753, GO:0042105, GO:0045060, GO:0045086, GO:0045879, GO:0046641, GO:0050731, GO:0050850, GO:0050852
GOTerms :
activation of alpha-beta T cell proliferation, activation of calcium-mediated signaling, activation of interferon-gamma production, activation of interleukin-2 biosynthetic process, activation of interleukin-4 production, activation of peptidyl-tyrosine phosphorylation, activation of T cell anergy, alpha-beta T lymphocyte receptor complex, alpha-beta T-cell receptor complex, alpha-beta TCR complex, alpha-beta T-lymphocyte receptor complex, c-SMAC, down regulation of smoothened signaling pathway, downregulation of smoothened signaling pathway, down-regulation of smoothened signaling pathway, GO:0004926, GO:0045877, inhibition of smoothened signaling pathway, juxtamembrane, negative regulation of hedgehog signaling pathway, negative regulation of hh signaling pathway, negative regulation of smoothened activity, negative regulation of smoothened by patched, negative regulation of smoothened receptor activity by patched, negative regulation of smoothened signalling pathway, negative thymic T lymphocyte selection, negative thymic T-cell selection, negative thymic T-lymphocyte selection, non G protein coupled 7TM receptor activity, non-G-protein coupled 7TM receptor activity, non-G-protein-coupled 7TM receptor activity, outer surface of cytoplasmic membrane, positive regulation of alpha-beta T lymphocyte proliferation, positive regulation of alpha-beta T-cell proliferation, positive regulation of alpha-beta T-lymphocyte proliferation, positive regulation of calcium-mediated signalling, positive regulation of IL-2 biosynthesis, positive regulation of IL-2 biosynthetic process, positive regulation of IL-4 production, positive regulation of interleukin-2 anabolism, positive regulation of interleukin-2 biosynthesis, positive regulation of interleukin-2 formation, positive regulation of interleukin-2 synthesis, positive regulation of T lymphocyte anergy, positive regulation of T-cell anergy, positive regulation of T-lymphocyte anergy, positive regulation of type II interferon production, stimulation of alpha-beta T cell proliferation, stimulation of calcium-mediated signaling, stimulation of interferon-gamma production, stimulation of interleukin-2 biosynthetic process, stimulation of interleukin-4 production, stimulation of peptidyl-tyrosine phosphorylation, stimulation of T cell anergy, supramolecular activation cluster, T lymphocyte receptor signaling pathway, T lymphocyte receptor signalling pathway, T-cell receptor signaling pathway, T-cell receptor signalling pathway, TCR signaling pathway, T-lymphocyte receptor signaling pathway, T-lymphocyte receptor signalling pathway, transmembrane, up regulation of alpha-beta T cell proliferation, up regulation of calcium-mediated signaling, up regulation of interferon-gamma production, up regulation of interleukin-2 biosynthetic process, up regulation of interleukin-4 production, up regulation of peptidyl-tyrosine phosphorylation, up regulation of T cell anergy, up-regulation of alpha-beta T cell proliferation, upregulation of alpha-beta T cell proliferation, up-regulation of calcium-mediated signaling, upregulation of calcium-mediated signaling, up-regulation of interferon-gamma production, upregulation of interferon-gamma production, up-regulation of interleukin-2 biosynthetic process, upregulation of interleukin-2 biosynthetic process, up-regulation of interleukin-4 production, upregulation of interleukin-4 production, up-regulation of peptidyl-tyrosine phosphorylation, upregulation of peptidyl-tyrosine phosphorylation, upregulation of T cell anergy, up-regulation of T cell anergy
UniprotAccessions :
P22646
Gene :
Cd3e
GeneID URL :
www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=12501
EntityFormats :
Purified, ALEXA FLUOR® 488, Biotin
UNSPSC :
12352203
Concentration :
IgG concentration 0.5mg/ml
ProductForm :
Purified IgG conjugated to Biotin - liquid
PriceDKK :
2032
PrimarySecondary :
Primary
PriceGBP :
196
PriceEUR :
273
PriceUSD :
273 USD
PriceCHF :
320
PriceSEK :
2721
PriceNOK :
2704
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.